key: cord-0791862-65blsl62
authors: Keikha, Reza; Jebali, Ali
title: Los biomarcadores neuroinflamatorios miARN en pacientes con COVID-19 con diferente gravedad de la enfermedad
date: 2021-07-16
journal: Neurologia
DOI: 10.1016/j.nrl.2021.06.005
sha: af9666324587fc84bfde5537bddb611e43db521b
doc_id: 791862
cord_uid: 65blsl62

Introduction: The expression of specific miRNAs and their mRNA targets are changed in infectious disease. The aim of this study was to analyze the expression of pro-neuroinflammatory miRNAs, anti- neuroinflammatory miRNAs, and their mRNA targets in the serum of COVID-19 patients with different grades. Methods: COVID-19 patients with different grades were enrolled in this study and the expression of pro-neuroinflammatory miRNAs, anti-neuroinflammatory miRNAs, and their target mRNAs was analyzed by q-PCR. Results: The relative expression of anti- neuroinflammatory miRNAs (mir-21, mir-124, and mir-146a) was decreased and the relative expression of their target mRNAs (IL-12p53, Stat3, and TRAF6) was increased. Also, the relative expression of pro-neuroinflammatory miRNAs (mir-326, mir-155, and mir-27b) was increased and the relative expression of their target mRNA (PPARS, SOCS1, and CEBPA) was decreased in COVID-19 patients with increase of disease grade. A negative significant correlation was seen between mir-21 and IL-12p53 mRNA, mir-124 and Stat3 mRNA, mir-146a and TRAF6 mRNA, mir-27b and PPARS mRNA, mir-155 and SOCS1 mRNA, and between mir-326 and CEBPA mRNA in COVID-19 patients (P<0.05). Conclusions: This study showed that the relative expression of anti- neuroinflammatory miRNAs was decreased and the relative expression of their targeted mRNAs was increased in COVID-19 patients from asymptomatic to critical illness. Also, this study showed that the relative expression of pro-neuroinflammatory miRNAs was increased and the relative expression of their targeted mRNA was decreased in COVID-19 patients from asymptomatic to critical illness. Introducción: La expresión de miARN específicos y sus dianas de ARNm se modifican en las enfermedades infecciosas. El objetivo de este estudio fue analizar la expresión de miARN pro-neuroinflamatorios, miARN anti-neuroinflamatorios y sus ARNm dianas en el suero de pacientes con COVID-19 de diferentes grados. Métodos: Se incluyeron en este estudio pacientes con COVID-19 de diferentes grados y se analizó la expresión de miARN pro-neuroinflamatorios, miARN anti-neuroinflamatorios y sus ARNm diana mediante q-PCR. Resultados: La expresión relativa de miARN anti-neuroinflamatorios (mir-21, mir-124 y mir-146a) disminuyó y la expresión relativa de sus ARNm diana (IL-12p53, Stat3 y TRAF6) aumentó. Además, la expresión relativa de miARN pro-neuroinflamatorios (mir-326, mir-155 y mir-27b) aumentó y la expresión relativa de su ARNm diana (PPARS, SOCS1 y CEBPA) disminuyó en pacientes con COVID-19 con aumento del grado de enfermedad. Se observó una correlación negativa significativa entre ARNm de mir-21 e IL-12p53, ARNm de mir-124 y Stat3, ARNm de mir-146a y TRAF6, ARNm de mir-27b y PPARS, ARNm de mir-155 y SOCS1, y entre mir-326 y ARNm de CEBPA en pacientes con COVID-19 (P <0,05). Conclusiones: Este estudio mostró que la expresión relativa de miARN anti-neuroinflamatorios disminuyó y la expresión relativa de sus ARNm diana se incrementó en pacientes con COVID-19 de enfermedad asintomática a crítica. Además, este estudio mostró que la expresión relativa de miARN pro-neuroinflamatorios aumentó y la expresión relativa de su ARNm diana disminuyó en pacientes con COVID-19 de enfermedad asintomática a crítica.

Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), known as COVID-19, is a new infectious disease first seen in late December 2019 in Wuhan, China, and similar outbreaks occurred in the hospital in neighboring countries. Major clinical symptoms include fever, dry J o u r n a l P r e -p r o o f 5 cough, diarrhea, muscle aches, pneumonia, and in severe cases death [1, 2] . COVID-19 also is associated with neurological manifestations such as encephalopathy and encephalomyelitis, ischemic stroke and intracerebral hemorrhage, anosmia, neuromuscular diseases, and neuroinflammation diseases [3] .

Since COVID-19 is a new disease, complete information on its etiology, cellular mechanisms, and possible risk factors is not available. COVID-19 may be similar to recent acute respiratory syndromes, such as SARS and MERS [4] . Theoretically, after the SARS-CoV-2 enters the human body, different types of immune cells are stimulated. These cells trigger the proper immune response by producing different cytokines, chemokines, antibodies, etc. SARS-CoV-2 can infect the CNS following the entry of the virus into the nose or the eye. The viral particles are transmitted to the olfactory bulb and then to the brainstem, and then all parts of the brain [5] .

In addition to the direct attack of nerve cells, the SARS-CoV-2 can systematically cross the BBB through the blood vessels and reach the CNS. The main feature of systemic infection in COVID- 19 is the massive increase in pro-inflammatory factors in the blood, which is described as a "cytokine storm" [6] . This leads to BBB permeability and transmission of SARS-CoV-2 and peripheral immune cells. Once the coronavirus enters the CNS, it is the turn of the astrocytes and microglia to fight it. The immune response of astrocytes and microglia is regulated by different microRNAs (miRNAs). Previous studies showed inflammatory processes in CNS are guided by pro-neuroinflammatory miRNAs (such as mir-155, mir-27b, mir-326) and antineuroinflammatory miRNAs (such as mir-146a, mir-124, and mir-21) [7, 8] .

This study aimed to analyze the expression of pro-neuroinflammatory miRNAs, antineuroinflammatory miRNAs, and their mRNA targets in the serum of COVID-19 patients with different grades.

All primers were provided from Bioneer, South Korea. MirPremier microRNA isolation kit was sourced from Sigma-Aldrich, USA. Mir-X miRNA First-Strand Synthesis kit and cDNA matermix were purchased from Takara bio inc, USA. SYBR® Green Real-Time Master Mix was from Invitrogen, UK.

In this study, to determine the miRNAs associated with the COVID-19, we used online bioinformatics Softwares [9] . In the first step, mirTarP (https://mcube.nju.edu.cn/jwang/mirTar/docs/mirTar/) was used to the list of appropriate miRNAs [10, 11] . In the second step, to reduce the number of selected miRNAs, we selected some limited pro-neuroinflammatory and anti-neuroinflammatory miRNAs that were previously reported in other studies. In the third step, the miRDB online database (http://mirdb.org/) was used to find the target of selected miRNAs [12] . Target genes of the differentially regulated miRNAs were predicted using the mirPath tool (version 3.0) [13] . KEGG molecular pathways were also retrieved using the same tool [14] . Pathways and processes regulated with P values lower than 0.05 were considered significant. 

Here, Small RNA was isolated from blood samples using mirPremier microRNA isolation kit.

Briefly, 1000 μL of the lysis buffer was added to 100 μL of serum samples, vortexed for 2 min, and incubated at 55 °C for 5 min. The samples were then centrifuged for 5 min at 14,000 x g to remove cellular debris, genomic DNA, and large RNA. The lysate supernatant was filtered through the filtration column and binding column. After binding, the column was first washed with 700 μL of 100% ethanol and centrifuged at 14,000 x g for 30 sec and again the flowthrough was discarded. The second wash was done by adding 500 μl of binding solution into the column and centrifuged at maximum speed (14,000 x g) for 1 min. Subsequently, 500 ml of the ethanol-diluted wash solution 2 was added to the column for a third wash. After centrifugation at maximum speed (14,000 x g) for 30 sec, the flow-through was discarded. Next, the column was 

All data were reported as the mean ± standard deviation. To find significant differences between groups, a one-way ANOVA method was applied. A p-value of less than 0.05 was considered statistically significant. Also, Spearman's correlation coefficient was used to correlate the expression of miRNAs and their mRNA targests

Five-top human mRNA targets for pro-neuroinflammatory miRNAs (mir-155, mir-27b, and mir-326) and anti-neuroinflammatory miRNAs (mir-124, mir-146a, and mir-21) are shown in Table   2 . It should be noted that each miRNA has many targets, but here we have listed only 5 important mRNA targets with the highest target score. Theoretically, all of them can be affected by pro-neuroinflammatory and anti-neuroinflammatory miRNAs.

Based on KEGG database ( Table 3) , we found that both pro-neuroinflammatory miRNAs and anti-neuroinflammatory miRNAs are significantly enriched in important cellular pathways, such as PI3K-Akt signaling pathway, mRNA surveillance pathway, mTOR signaling pathway, MAPK signaling pathway, Wnt signaling pathway, and AMPK signaling pathway.

We found that the relative expression of anti-neuroinflammatory miRNAs, including mir-21, mir-124, and mir-146a, was significantly decreased with increase of COVID-19 grade (P<0.05) (Figure 1(a-c) ). Interestingly, the relative expression of human mRNA targets, including IL-12p53, Stat3, and TRAF6, of anti-neuroinflammatory miRNAs was significantly increased with increase of COVID-19 grade (P<0.05) (Figure 2(a-c) ). A negative significant correlation was seen between the expression of (mir-21 and IL-12p53 mRNA), (mir-124 and Stat3 mRNA), and (mir-146a and TRAF6 mRNA) in COVID-19 patients at all grades (P<0.05) (Figure 3(a-c) ).

The relative expression of pro-neuroinflammatory miRNAs, including mir-326, mir-155, and mir-27b, was significantly increased with increase of COVID-19 grade (P<0.05) (Figure 4(a-c) ).

Interestingly, the relative expression of human mRNA targets, including PPARS, SOCS1, and CEBPA, of pro-neuroinflammatory miRNAs was significantly decreased with increase of COVID-19 grade (P<0.05) (Figure 5(a-c) ). A negative significant correlation was also seen between the expression of (mir-27b and PPARS mRNA), (mir-155 and SOCS1 mRNA), and (mir-326 and CEBPA mRNA) in COVID-19 patients at all grades (P<0.05) (Figure 6(a-c) ).

This study showed that the relative expression of anti-neuroinflammatory miRNAs (mir-21, mir-124, and mir-146a) was decreased and the relative expression of their target mRNAs (IL-12p53, Stat3, and TRAF6) was increased in COVID-19 patients with increase of disease grade from asymptomatic to critical illness. Also, this study showed that the relative expression of pro-neuroinflammatory miRNAs (mir-326, mir-155, and mir-27b) was increased and the relative expression of their target mRNA (PPARS, SOCS1, and CEBPA) was decreased in COVID-19

patients with increase of disease grade. A negative significant correlation was seen between each miRNA and its target mRNA. Based on bioinformatics analysis, some important pathways are affected by these pro-neuroinflammatory and anti-neuroinflammatory miRNAs, including PI3K-Akt, mRNA surveillance, mTOR, MAPK, Wnt, and AMPK signaling pathways. What we have found is that in patients with high severity of illness, the expression of pro-inflammatory miRNAs is increased, and conversely, the expression of anti-inflammatory miRNAs is decreased. Of course, it is clear that this situation follows a cytokine storm. Unfortunately, we have to say that this special condition not only causes serious damage to the brain but also causes damage to several organs and leads to multiple organ failure. We think that when immune cells are highly stimulated, cytokines and miRNAs can travel through the bloodstream to the whole body. This phenomenon has been mentioned by some researchers [15, 16] .

Mir-155 is a central pro-inflammatory mediator in CNS by NF-κB dependent TLR signaling. It is synthesized inside macrophages and microglia [17] [18] [19] . mir-155 targets anti-inflammatory regulators such as SOCS1 [17, 19] , SHIP1 [20] , C/EBP-β [21] and IL13Rα1 [22] . mir-155

inhibits the suppression of anti-inflammatory signaling and induces neuroinflammation. When mir-155 is expressed, it stimulates the transcription factor p53, and it targets the c-Maf transcription factor, which induces differentiation and inflammatory responses [23] . Mir-146a is an anti-inflammatory regulator in nerve cells, microglia, and astrocytes. It activates by NF-κB dependent TLR signaling [24, 25] . The Mir-146a targets MyD88 signaling complex, including IRAK1 and TRAF6, and acts as an NF-κB signaling regulator. In addition, Mir-146a targets other pro-inflammatory mediators including STAT-1 [26, 27] , IRF-5 [27] and CFH [28, 29] . The polarization of macrophages and microglia are also altered by mir-146a [30] . mir-124 is also an anti-inflammatory miRNA and has a major role in neuronal differentiation [31] and is highly expressed in microglia under normal conditions, but is not expressed in peripheral macrophages [32] . Expression of mir-124 in microglia leads to anti-inflammatory effects [33] by M2 phenotype [34] . It is clear that mir-124 has anti-inflammatory activity by reducing inflammatory mediators and limiting microglia to activity. The role of mir-21 is very prominent in different types of CNS cells such as microglia [35] and astrocytes [36] , neurons [37] , and oligodendrocytes [38] . Mir-21 is an anti-inflammatory regulator activated by TLR signaling.

This induces the expression of the anti-inflammatory cytokine such as IL-10 [39] . In addition, mir-21 decreases TNF-α secretion in macrophages and microglia [40] . mir-27b targets an antiinflammatory transcriptional activator, PPAR-γ; in human macrophages, this interaction blocks the induction of an anti-inflammatory phenotype. Inhibiting mir-27b also limits inflammatory signaling. It leads to produce inflammatory cytokines including IL-6 and TNF-α [41] . mir-326 is another pro-inflammatory miRNAs and can affect on differentiation of IL-17-producing Th17 cells. It was found that silencing mir-326 reduced EAE pathology [42] . miRNAs have a cumulative effect on neuronal signaling and act together in inflammatory or anti-inflammatory pathways. For example, both mir-146a and mir-21 target different components of the TLR / MyD88 / NF-κB and JAK-STAT pathways [26, 28] . In contrast, mir-155, mir-27b, and mir-326 activate the JAK-STAT pathway by targeting SOCS1 and SHIP1 [19] . It is interesting to note that miRNAs are also present in extracellular exosomes and can participate in intercellular communication [43] . For example, mir-124, mir-21, and let-7 are found in exosomes and stimulate and regulate adjacent cells such as microglia and contribute to inflammatory signaling [44] .

One of main limitations of this study was to find and to collect COVID-19 patients with no comorbidities, no inflammatory autoimmune diseases, and no drug treatments. Theoretically, these factors can affect the expression of mRNAs and miRNAs. Second limitation was that we did not include COVID-19 patients caused by different variants of SARS-COV-2. Here, only COVID-19 patients with English variant (Lineage B.1.1.7) were included. We think that the expression of mRNAs and miRNAs may also be affected by virus variants. The third limitation was that we evaluated only 6 neuroinflammatory miRNAs in COVID-19 patients and it is suggested that other neuroinflammatory miRNAs could be studied in future studies.

This study showed that the relative expression of anti-neuroinflammatory miRNAs (mir-21, mir-124, and mir-146a) was decreased and the relative expression of their mRNAs (IL-12p53, Stat3, and TRAF6) was increased in COVID-19 patients from asymptomatic to critical illness. Also, this study showed that the relative expression of pro-neuroinflammatory miRNAs (mir-326, mir-155, and mir-27b) was increased and the relative expression of their mRNA (PPARS, SOCS1, and CEBPA) was decreased in COVID-19 patients from asymptomatic to critical illness. A negative significant correlation was seen between mir-21 and IL-12p53 mRNA, mir-124 and Stat3, . Table 3 . Important pathways of pro-neuroinflammatory miRNAs and anti-neuroinflammatory miRNAs, extracted from KEGG molecular pathway.

The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak

Coronavirus disease 2019 (COVID-19): a perspective from China. Radiology

Neurological manifestations of COVID-19"-guideline of the German society of neurology

The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?

Middle East respiratory syndrome coronavirus causes multiple organ damage and lethal disease in mice transgenic for human dipeptidyl peptidase 4. The Journal of infectious diseases

The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system

MicroRNAs: roles in regulating neuroinflammation

MicroRNAs in neuroinflammation: implications in disease pathogenesis, biomarker discovery and therapeutic applications. Non-coding RNA

Computational methods for microRNA target prediction

Predicting MicroRNA Mediated Gene Regulation between Human and Viruses. Cells

Identification of novel SARS-CoV-2 drug targets by host microRNAs and transcription factors co-regulatory interaction network analysis. Frontiers in genetics

miRDB: an online resource for microRNA target prediction and functional annotations

DIANA-miRPath v3. 0: deciphering microRNA function with experimental support

The KEGG databases at GenomeNet. Nucleic acids research

Cardiac dysfunction and thrombocytopenia-associated multiple organ failure inflammation phenotype in a severe paediatric case of COVID-19. The Lancet Child & Adolescent Health

Comorbidities and multi-organ injuries in the treatment of COVID-19. The Lancet

Inducible microRNA-155 feedback promotes type I IFN signaling in antiviral innate immunity by targeting suppressor of cytokine signaling 1. The journal of immunology

Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor α (TNFα) production via increased mRNA half-life in alcoholic liver disease

miR-155 modulates microglia-mediated immune response by downregulating SOCS-1 and promoting cytokine and nitric oxide production

Inositol phosphatase SHIP1 is a primary target of miR-155

Silencing of microRNA-155 in mice during acute inflammatory response leads to derepression of c/ebp Beta and down-regulation of G-CSF

IL-13) pathway in human macrophages is modulated by microRNA-155 via direct targeting of interleukin 13 receptor α1 (IL13Rα1)

The p53 transcription factor modulates microglia behavior through microRNA-dependent regulation of c-Maf

NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses

Differential regulation of interleukin-1 receptor-associated kinase-1 (IRAK-1) and IRAK-2 by microRNA-146a and NF-κB in stressed human astroglial cells and in Alzheimer disease

MicroR-146 blocks the activation of M1 macrophage by targeting signal transducer and activator of transcription 1 in hepatic schistosomiasis. EBioMedicine

MicroRNA-146a contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins

Differential expression of miRNA-146a-regulated inflammatory genes in human primary neural, astroglial and microglial cells

An NF-κB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells

MiR-146a modulates macrophage polarization by inhibiting Notch1 pathway in RAW264. 7 macrophages

The MicroRNA miR-124 promotes neuronal differentiation by triggering brain-specific alternative pre-mRNA splicing. Molecular cell

MicroRNA-124 promotes microglia quiescence and suppresses EAE by deactivating macrophages via the C/EBP-α-PU. 1 pathway. Nature medicine

microRNA-124 negatively regulates TLR signaling in alveolar macrophages in response to mycobacterial infection

IL-4/IL-13-dependent and independent expression of miR-124 and its contribution to M2 phenotype of monocytic cells in normal conditions and during allergic inflammation

miR-21 represses FasL in microglia and protects against microgliamediated neuronal cell death following hypoxia/ischemia

Inhibition of miR-21 ameliorates excessive astrocyte activation and promotes axon regeneration following optic nerve crush

miR-21 alleviated apoptosis of cortical neurons through promoting PTEN-Akt signaling pathway in vitro after experimental traumatic brain injury

MicroRNA-21: expression in oligodendrocytes and correlation with low myelin mRNAs in depression and alcoholism

Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21

Anti-inflammatory effects of miR-21 in the macrophage response to peritonitis

MicroRNA-27b contributes to lipopolysaccharide-mediated peroxisome proliferator-activated receptor γ (PPARγ) mRNA destabilization

MicroRNA miR-326 regulates T H-17 differentiation and is associated with the pathogenesis of multiple sclerosis

Cell-to-cell communication: microRNAs as hormones. Molecular oncology

Exosomes from NSC-34 cells transfected with hSOD1-G93A are enriched in miR-124 and drive alterations in microglia phenotype

There is no conflict of interest.